Suchergebnisse - "GE SHUSHAN"

PubPharm (27)

1

IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2024

von Yu, L. | Xu, L. | Chen, Y. | +8

2

A novel 68Ga-labeled cyclic peptide molecular probe based on the computer-aided design for noninvasive imaging of PD-L1 expression in tumors

enthalten in: Bioorganic chemistry | 2023

von Ge, S. | Zhang, B. | Li, J. | +6

3

Targeted tumor PD-L1 PET (Polyethylene Terephthalate) imaging agent labeling precursor, imaging agent as well as synthesis method and application of imaging agent

enthalten in: Europäisches Patentamt | 2023

von GE SHUSHAN | DENG SHENGMING | ZHANG BIN | +6

4

Correction : Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2023

von Liu, W. | Zou, Y. | Li, K. | +7

ErratumFor: J Immunol. 2022 Jul 1;209(1):180-191. - PMID 35725271

5

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer

enthalten in: Frontiers in oncology | 2023

von Jia, T. | Lv, Q. | Cai, X. | +5

6

Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer

enthalten in: International immunopharmacology | 2022

von Yu, L. | Wang, Y. | He, Y. | +8

7

Molecular imaging of immune checkpoints in oncology : Current and future applications

enthalten in: Cancer letters | 2022

von Ge, S. | Jia, T. | Li, J. | +3

8

Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2022

von Liu, W. | Zou, Y. | Li, K. | +7

ErratumIn: J Immunol. 2023 Jul 1;211(1):163. - PMID 37195178

9

Indoline compound as well as derivative, preparation method, pharmaceutical composition and application thereof

enthalten in: Europäisches Patentamt | 2022

von LAI YISHENG | HU BIYUN | MA XUEWEI | +5

10

Prognostic value of 18F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer : A large single-center cohort study

enthalten in: Frontiers in oncology | 2022

von Li, J. | Zhang, B. | Ge, S. | +3